Australia TGA ARTG record

Femoral stem centralizer

Australia TGA ARTG Registered Device · Johnson & Johnson Medical Pty Ltd t/a DePuy Synthes · Depuy International · Class IIb · Started December 13, 2023

Good Name: Johnson & Johnson Medical Pty Ltd t/a DePuy Synthes - Femoral stem centralizer

Device classification

Risk Class: Class IIb
Product Type: Single Device Product
ARTG Category: General

Registration information

Start Date: December 13, 2023
Effective Date: December 13, 2023

Sponsor

Name: Johnson & Johnson Medical Pty Ltd t/a DePuy Synthes

Manufacturer

Name: Depuy International
Country: United Kingdom
Address: St Anthony's Road, LEEDS, WEST YORKSHIRE, LS118DT

Intended purpose

To be used during the implantation of a cemented femoral stem prosthesis to centralize and stabilize the prosthesis tip within the femoral medullary canal.

About this record

Access comprehensive regulatory information for Femoral stem centralizer in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is sponsored by Johnson & Johnson Medical Pty Ltd t/a DePuy Synthes, manufactured by Depuy International in United Kingdom. The device registration started on December 13, 2023.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.